Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-24T23:46:59.206Z Has data issue: false hasContentIssue false
  • English
  • Français

Toxic epidermal necrolysis after paroxetine treatment

Published online by Cambridge University Press:  16 April 2020

P Wolkenstein ,
D Cremniter  and
JC Roujeau
P Wolkenstein
Affiliation:
Department of Dermatology, Hôpital Henri-Mondor, 94010Créteil, France
D Cremniter
Affiliation:
Department of Psychiatry, Hôpital Henri-Mondor, 94010Créteil, France
JC Roujeau
Affiliation:
Department of Dermatology, Hôpital Henri-Mondor, 94010Créteil, France

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
European Psychiatry , Volume 10 , Issue 3 , 1995 , pp. 162
Copyright
Copyright © Elsevier, Paris 1995

References

Bodokh, ILacour, PhRosenthal, Eet al.Syndrome de Lyell ou nécrolyse épidermique toxique et syndrome de Stevens-Johnson après traitement par fluoxétine. Thérapie 1992; 47: 441Google Scholar
Freeman, CPFluvoxamine: clinical trials and clinical use. J Psychiatr Neurosci 1991; 16: 19–25Google ScholarPubMed
Menard, GAllain, HBeneton, CN'Guyen, JMEnquête épidémiologique sur la prescription d'antidépresseurs. Psychol Med 1992; 24: 1550–4Google Scholar
Srebmik, AHes, JPBrenner, SAdverse cutaneous reactions to psychotropic drugs Acta Derm Ven (Stockh) 1991; 71 (suppl 158): 3–12Google Scholar
Wagner, WPlekkenpol, BGray, TEVlaskamp, HEssers, HReview of fluvoxamine safety database Drugs 1992; 43 (suppl 2) 48–54CrossRefGoogle ScholarPubMed
Wolkenstein, PRevuz, JDiehl, JLLangeron, ORoupie, EMachet, LToxic epidermal necrolysis after fluvoxamine. Lancet 1993; 31: 304–5CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.